Poseida Therapeutics, Inc. - stock earnings
PSTX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -24.0 million USD | 25.0 million USD |
| 2023Q3 | -31.8 million USD | 9.4 million USD |
| 2023Q2 | -27.5 million USD | 20.0 million USD |
| 2023Q1 | -40.2 million USD | 10.3 million USD |
| 2022Q4 | -33.3 million USD | 9.9 million USD |
| 2022Q3 | 70.4 million USD | 116.3 million USD |
| 2022Q2 | -44.5 million USD | 2.7 million USD |
| 2022Q1 | -59.2 million USD | 1.4 million USD |
| 2021Q4 | 1469 USD | 31238 USD |
| 2021Q3 | -42.4 million USD | ? USD |
| 2021Q2 | -45.7 million USD | ? USD |
| 2021Q1 | -38.3 million USD | ? USD |
| 2020Q4 | -36148 USD | ? USD |
| 2020Q3 | -34.4 million USD | ? USD |
| 2020Q2 | -30.4 million USD | ? USD |
| 2020Q1 | -28.8 million USD | ? USD |
| 2019Q4 | -23.6 million USD | ? USD |
| 2019Q3 | -21.0 million USD | ? USD |
| 2019Q2 | -28.6 million USD | ? USD |
| 2019Q1 | -13.3 million USD | ? USD |
PSTX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -123.4 million USD | 64.7 million USD |
| 2022 | -64.0 million USD | 130.4 million USD |
| 2021 | 4.4 million USD | 31238 USD |
| 2020 | 2.5 million USD | ? USD |
| 2019 | -92.6 million USD | ? USD |
| 2018 | -44.4 million USD | ? USD |
| 2017 | -19.7 million USD | 3.0 million USD |
PSTX
Price: $2.79
52 week price:
Earnings Per Share: -1.37 USD
P/E Ratio: -2.27
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 268000
Market Capitalization: 262.4 million